US Patent 11040051 Formulation comprising a gemcitabine-prodrug
Patent 11040051 was granted and assigned to NuCana on June, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11040051 Formulation comprising a gemcitabine-prodrug
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.